Obermatt
See Similar Stocks →

Achieve Life Sciences

NAQ:ACHV · US0044685008
BiotechnologySmall

360° View

63
Price/Sales21
Price/Earnings69
Price/Book87
Dividend Yield1
Revenue Growth—
Profit Growth67
Capital Growth100
TSR 52w52
Leverage15
Liquidity33
Refinancing55
Combined66
Analyst Opinions57
Pro Holdings25
Opinion Changes50
Market Pulse68

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees35
Websiteachievelifesciences.com
ISINUS0044685008
Last UpdateApr 2, 2026
Index & Theme
AddictionCentral Nervous SystemBiotechnologyLife SciencePharmaceutical

Description

Achieve Life Sciences, Inc. operates as a late-stage clinical specialty pharmaceutical company. The company expects to file a New Drug Application, or NDA, with the FDA for the treatment of nicotine dependence for smoking cessation at the end of the…

Analysis

Achieve Life Sciences's 360° View rank of 63 places it above its peer average — better than 63% of its true peers.

It's a growth standout (94) and reasonably valued (59). On safety it is highly leveraged (16), and the market shows favorable sentiment (53). Taken together, its Combined rank of 66 reads as above its peer average.

360° rank · history

1007550250
63
2026

All-time high

63

Jun 2026

All-time low

58

Mar 2026

Average rank

61

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
21
—
—
—
Price/Earnings
69
—
—
—
Price/Book
87
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
59
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Achieve Life Sciences with its peers
Vor Biopharma
NSQ:VOR
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Gain Therapeutics
NMQ:GANX
59
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Sangamo Therapeutics
NAQ:SGMO
34
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vera Therapeutics
NMQ:VERA
44
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Invivyd
NMQ:IVVD
40
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
BIOAGE Labs
NSQ:BIOA
23
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →